Correlation Between Royal Bank and Medicenna Therapeutics Cor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Royal Bank and Medicenna Therapeutics Cor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Bank and Medicenna Therapeutics Cor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royal Bank of and Medicenna Therapeutics Corp, you can compare the effects of market volatilities on Royal Bank and Medicenna Therapeutics Cor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Bank with a short position of Medicenna Therapeutics Cor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Bank and Medicenna Therapeutics Cor.

Diversification Opportunities for Royal Bank and Medicenna Therapeutics Cor

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Royal and Medicenna is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Royal Bank of and Medicenna Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicenna Therapeutics Cor and Royal Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Bank of are associated (or correlated) with Medicenna Therapeutics Cor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicenna Therapeutics Cor has no effect on the direction of Royal Bank i.e., Royal Bank and Medicenna Therapeutics Cor go up and down completely randomly.

Pair Corralation between Royal Bank and Medicenna Therapeutics Cor

Assuming the 90 days trading horizon Royal Bank of is expected to generate 0.09 times more return on investment than Medicenna Therapeutics Cor. However, Royal Bank of is 11.34 times less risky than Medicenna Therapeutics Cor. It trades about -0.05 of its potential returns per unit of risk. Medicenna Therapeutics Corp is currently generating about -0.17 per unit of risk. If you would invest  2,574  in Royal Bank of on December 4, 2024 and sell it today you would lose (27.00) from holding Royal Bank of or give up 1.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Royal Bank of  vs.  Medicenna Therapeutics Corp

 Performance 
       Timeline  
Royal Bank 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Royal Bank of has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Royal Bank is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Medicenna Therapeutics Cor 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Royal Bank and Medicenna Therapeutics Cor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Royal Bank and Medicenna Therapeutics Cor

The main advantage of trading using opposite Royal Bank and Medicenna Therapeutics Cor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Bank position performs unexpectedly, Medicenna Therapeutics Cor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics Cor will offset losses from the drop in Medicenna Therapeutics Cor's long position.
The idea behind Royal Bank of and Medicenna Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk